Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neramexane for subjective tinnitus
2008-000639-16Phase 3Completed
- Sponsor
- Merz
- Start
- Jul 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of neramexane in tinnitus (4 arms), sponsored by Merz. Primary endpoints: Change in TBF-12 score from baseline to Week 17/EOT and Change in TRS item tinnitus annoyance from baseline to EOT. Started Jul 2008; status: completed.
02
Drugs
neramexane
03
Conditions
tinnitus
Beyond the preview
Go deeper on 2008-000639-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-000639-16.